Filing Flows › Comparisons › ABBV vs PFE
AbbVie vs Pfizer: ABBV and PFE compared
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $16.6B for Pfizer (Q3 2026). AbbVie is growing faster (+10% against -0.4% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 20.4%.
Where the money goes: ABBV and PFE
AbbVie (ABBV) · Q3 2026
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Pfizer (PFE) · Q3 2026
Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.
| AbbVie (ABBV) | Pfizer (PFE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $17.4B | $16.6B |
| Revenue growth, Y/Y | +10% | -0.4% |
| Operating margin | 36.0% | 20.4% |
| Net earnings | $4.2B | $3.3B |
| Net margin | 24.2% | 19.6% |
| Operating cash flow | $7.6B | $5.4B |
| Free cash flow | $7.3B | $4.8B |
| Market value | $516.2B | $169.0B |
| P/E | 50.1× | 42.0× |
| Analysts’ mean target | $310.65 | $30.11 |
Questions
Which is bigger, AbbVie or Pfizer?
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $16.6B for Pfizer (Q3 2026).
Is AbbVie or Pfizer growing faster?
AbbVie is growing faster (+10% against -0.4% a year earlier).
Which is more profitable, AbbVie or Pfizer?
AbbVie is more profitable, with an operating margin of 36.0% against 20.4%.
More: AbbVie earnings · how AbbVie makes money · Pfizer earnings · how Pfizer makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.